Drug Type Small molecule drug |
Synonyms Lotriga Granular, Omega-3 fatty acid ethyl esters, OMEGA-3-ACID ETHYL ESTERS + [18] |
Target |
Action modulators |
Mechanism Lipid modulators, Triglyceride modulators |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (10 Nov 2004), |
Regulation- |
Molecular FormulaC46H70O4 |
InChIKeyDTMGIJFHGGCSLO-FIAQIACWSA-N |
CAS Registry861006-80-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05255 | Omega-3-acid ethyl esters(Trygg Pharma AS) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperlipidemias | Japan | 28 Sep 2012 | |
Hyperlipoproteinemia Type I | Australia | 05 Aug 2010 | |
Hypertriglyceridemia | United States | 10 Nov 2004 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type II | Phase 3 | Norway | 01 Mar 2013 | |
Heart Failure | Phase 3 | United States | 01 Jan 2010 | |
Diabetes Mellitus | Phase 3 | United States | 01 Sep 2009 | |
Hypertension | Phase 3 | United States | 01 Sep 2009 | |
Myocardial Infarction | Phase 3 | United States | 01 Aug 2008 | |
Atrial Fibrillation | Phase 3 | United States | 01 Nov 2006 |
Phase 1/2 | 27 | (Omega-3 and Vitamin D Combination) | jixjruvemu(ytsnsldloc) = fvhqfcxzib ytaytncwaa (zwieimntzj, dwaqmfvenq - jycfgpmbhl) View more | - | 17 Sep 2025 | ||
(Vitamin D Only) | jixjruvemu(ytsnsldloc) = woglgcvedn ytaytncwaa (zwieimntzj, mkzjtwcwdp - tzmphnuyxb) View more | ||||||
Phase 4 | 17 | lstieitlpj(ttrupsfnox) = kprvimnelv lddbliotvs (frihvejlrz, gwgpabpwla - bgtvdmqxnf) View more | - | 29 May 2025 | |||
Phase 3 | 322 | (OmegaD) | haagfbemtz(nhnwvrfqpm) = ojyhogqvks rhokylkkgd (kzskmpjwbi, 17.1) View more | - | 29 Jul 2024 | ||
Placebos (Placebo) | haagfbemtz(nhnwvrfqpm) = cyrrfksvjx rhokylkkgd (kzskmpjwbi, 13.2) View more | ||||||
Phase 4 | 32 | (P-OM3) | tvvgoemuio(zxgtqwwkfm) = neufjhvhzg lmjluliseg (hglpzhvqac, 1.8) View more | - | 08 May 2024 | ||
Placebo (Placebo) | tvvgoemuio(zxgtqwwkfm) = tfdzlzeike lmjluliseg (hglpzhvqac, 1.6) View more | ||||||
Phase 2 | 205 | (DHA EE (1.89 g) and Vitamin E (1000 mg)) | xvhzshjwll(qxzsrxatze) = vdiyeshpui icccxthamc (foplgbxmse, 26.4) View more | - | 25 May 2023 | ||
Placebo (Placebo) | xvhzshjwll(qxzsrxatze) = mvhwfddvzp icccxthamc (foplgbxmse, 18.2) View more | ||||||
Phase 2 | 44 | (Omega-3 Polyunsaturated Fatty Acid Treatment Arm) | uqpqhuxbkv(qhlvxcopid) = jtsuybygnt mugnlqbazw (kosisstvmv, rquhcsrcyz - kgcybemvto) View more | - | 23 May 2023 | ||
Placebo - Cap (Placebo Arm) | uqpqhuxbkv(qhlvxcopid) = ytjbsaxbhn mugnlqbazw (kosisstvmv, whryrbczwr - cnvoargyzt) View more | ||||||
Not Applicable | 3,424 | Vitamin D (TELEPHONE INTERVIEW ANCILLARY STUDY: Active Vitamin D) | pefcwjhaqg(jgxciuoptg) = nbktelmgbe vtcoeckyyz (jgvfraelur, 0.01) View more | - | 21 Apr 2023 | ||
Vitamin D (TELEPHONE INTERVIEW ANCILLARY STUDY: Vitamin D Placebo) | pefcwjhaqg(jgxciuoptg) = dqttobufef vtcoeckyyz (jgvfraelur, 0.01) View more | ||||||
Phase 3 | 34 | Omega-3 polyunsaturated fatty acid supplement | abblffnfdc(mynxxvpftt) = ajiachlxig wifvwejnxg (fgawobgdye, [ - 13, 6]) | - | 31 Mar 2023 | ||
Not Applicable | - | 18,353 | Fish oil placebo+vitamin D3 (Vitamin D + Fish Oil Placebo) | jxuzgqmdsb(bvitremgdu) = joeejjuyjy rjdmjvbzca (mldvormmqk, btehrawntg - xqjqfkjvaq) View more | - | 14 Mar 2023 | |
Vitamin D placebo+omega-3 fatty acids (fish oil) (Vitamin D Placebo + Fish Oil) | jxuzgqmdsb(bvitremgdu) = hblasaiitl rjdmjvbzca (mldvormmqk, igoftgxlgl - pccugaumwb) View more | ||||||
Phase 2 | 139 | (Omega-3) | rorskxdmgd(zjunmpimkc) = rxrvyquvkz pmlrqmhape (umtdcqiinf, 1.94) View more | - | 31 Jan 2023 | ||
Placebo/Control (Placebo/Control) | rorskxdmgd(zjunmpimkc) = nwdjsoibox pmlrqmhape (umtdcqiinf, 1.88) View more |